Kinney Horn
Corporate Officer/Principal en IMMUNOME, INC. .
Fortuna: 27 825 $ al 31/03/2024
Perfil
Mr. Kinney Horn is a Chief Business Officer at Immunome, Inc. Mr. Horn was previously employed as a Chief Business Officer by Olema Pharmaceuticals, Inc. and a Director-Business Development by Genentech, Inc. He received his undergraduate degree from the University of Mary Washington and a graduate degree from Georgetown University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/02/2023 | 2 458 ( 0.00% ) | 27 825 $ | 31/03/2024 |
Cargos activos de Kinney Horn
| Empresas | Cargo | Inicio |
|---|---|---|
| IMMUNOME, INC. | Corporate Officer/Principal | 01/02/2024 |
Antiguos cargos conocidos de Kinney Horn.
| Empresas | Cargo | Fin |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 24/03/2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/04/2019 |
Formación de Kinney Horn.
| Georgetown University | Graduate Degree |
| University of Mary Washington | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| IMMUNOME, INC. | Health Technology |
| OLEMA PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Kinney Horn
